Quarterly report pursuant to Section 13 or 15(d)

Share-based Compensation (Details)

v3.22.1
Share-based Compensation (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Oct. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)     300,000 700,000  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)     $ 480.67 $ 269.64  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)     $ 119.10 $ 57.50  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in shares)     555,103 505,137  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value     $ 196.3 $ 108.0  
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total $ 41.7   $ 41.7    
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)     2 years 1 month 6 days    
Employee Stock Purchase Plan 2014 [Member]          
Share-based Payment Arrangement, Expense   $ 0.4 $ 0.6 0.8  
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)         200,000
Selling, General and Administrative Expenses [Member]          
Share-based Payment Arrangement, Expense 8.7 11.1 35.9 36.0  
Cost of Sales [Member]          
Share-based Payment Arrangement, Expense $ 0.4 $ 0.4 $ 1.1 $ 1.5  
Restricted Stock Units (RSUs) [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)     27,573 23,367  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)     $ 470.38 $ 269.87  
Restricted Stock [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)     6,896 11,803  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)     $ 489.34 $ 264.73